Randomized evaluation of 5-month Ticagrelor monotherapy after 1-month dual-antiplatelet therapy in patients with acute coronary syndrome treated with drug-coated balloons: REC-CAGEFREE II trial rationale and design

Abstract Background Patients treated with drug-coated balloons (DCB) have the theoretical advantage of adopting a low-intensity antiplatelet regimen due to the absence of struts and polymers. Nevertheless, the optimal antiplatelet strategy for patients undergoing DCB-only treatment remains a topic o...

Descripció completa

Dades bibliogràfiques

Autors principals:	Chao Gao, Bin Zhu, Jianzheng Liu, Zhiwei Jiang, Tao Hu, Qiong Wang, Yi Liu, Ming Yuan, Fei Li, Ruining Zhang, Jielai Xia, Yoshinobu Onuma, Duolao Wang, Patrick Serruys, Ling Tao, on behalf of the REC-CAGEFREE II Study Group
Format:	Artigo
Idioma:	Inglês
Publicat:	BMC 2024-01-01
Col·lecció:	BMC Cardiovascular Disorders
Matèries:	Drug-coated balloon Dual antiplatelet therapy Acute coronary syndrome
Accés en línia:	https://doi.org/10.1186/s12872-024-03709-1
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!